Earth Science Tech, Inc. (ETST) Sees DEA Decision to Reschedule CBD Opening Doors for Development of Treatments for Multiple Illnesses
U.S. Drug Enforcement Agency’s (DEA) decision to remove certain CBD products from its Schedule 1 list of controlled substances will make CBD clinical studies easier to plan ETST’s pipeline includes CBD-based pharmaceutical formulas; company expects its pure hemp oil and new formulas to eventually be sold worldwide ETST will be a licensed distributor and plans to work closely with pharmacists and researchers to serve this market; it plans to launch two CBD nutraceutical formulas Earth Science Tech, Inc.’s (OTCQB: ETST) anticipation that its pure hemp oil and new formulas will eventually be sold globally and that it will be a…